|Bid||63.00 x 800|
|Ask||0.00 x 1800|
|Day's range||67.42 - 68.77|
|52-week range||26.49 - 73.63|
|Beta (5Y monthly)||1.52|
|PE ratio (TTM)||36.51|
|Earnings date||04 Nov 2020 - 09 Nov 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||77.73|
Investors seem to be impressed with National Vision's (EYE) better-than-expected second-quarter 2020 results despite the coronavirus-led economic crisis.
Syneos Health (SYNH) wins 35 COVID-19 related projects through the second quarter.
Hologic Launches Validated Pooling Protocol for COVID-19 Testing